2018
DOI: 10.1016/j.forsciint.2018.05.051
|View full text |Cite
|
Sign up to set email alerts
|

High-sensitive cardiac troponin hs-TnT levels in sudden deaths related to atherosclerotic coronary artery disease

Abstract: The measurement of hs-TnT serum values might be considered as an ancillary tool for the evaluation of death related to IHD, while taking necessary precautions in the interpretation of the results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
4

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 28 publications
0
8
0
4
Order By: Relevance
“…Also other candidate biomarkers, such as hFABP, GPBB, S100, PAPP-A, CRP, TNF, IL6, IL18, CD40 ligand, MPO, MMP9, cell-adhesion molecules, oxidized LDL, glutathione, homocysteine, fibrinogen, and D-dimer procalcitonin may play a role in the diagnosis of AMI. Many of these candidate-markers result obtained with hFABP, S100A 1 protein, fibrinogen, or others in the myocardial tissue of subjects dead from myocardial ischemia (by immunohistochemistry) were also analyzed in forensic literature to obtain a better diagnosis of early evolving MI 6466…”
Section: Resultsmentioning
confidence: 99%
“…Also other candidate biomarkers, such as hFABP, GPBB, S100, PAPP-A, CRP, TNF, IL6, IL18, CD40 ligand, MPO, MMP9, cell-adhesion molecules, oxidized LDL, glutathione, homocysteine, fibrinogen, and D-dimer procalcitonin may play a role in the diagnosis of AMI. Many of these candidate-markers result obtained with hFABP, S100A 1 protein, fibrinogen, or others in the myocardial tissue of subjects dead from myocardial ischemia (by immunohistochemistry) were also analyzed in forensic literature to obtain a better diagnosis of early evolving MI 6466…”
Section: Resultsmentioning
confidence: 99%
“…For the postmortem cTn I levels in serum, five of the included 13 studies (Pérez-Cárceles et al, 2004 [27]; Martínez Díaz et al, 2005 [28]; Batalis et al, 2010 [30]; Sun et al, 2011 [31]; and Carvajal-Zarrabal et al, 2017 [35]) compared the differences between the cardiac death and control groups, of which, four studies (Pérez-Cárceles et al, 2004 [27]; Martínez Díaz et al, 2005 [28]; Batalis et al, 2010 [30]; and Sun et al, 2011 [31]) recruited patients who died of myocardial infarction. For the postmortem cTn T levels in serum, senen of the included 13 studies (Zhu et al, 2003 [25]; Ellingsen et al, 2004 [26]; Khalifa et al, 2006 [29]; Remmer et al, 2013 [32]; Carvajal-Zarrabal et al, 2017 [35]; Beausire et al, 2018 [36]; and Rahimi et al, 2018 [24]) focused on the comparisons of postmortem cTn T concentrations in serum between the cardiac death and noncardiac death groups, and four of the seven studies (Zhu et al, 2003 [25]; Ellingsen et al, 2004 [26]; Khalifa et al, 2006 [29]; and Rahimi et al, 2018 [24]) used cases in which the patients died of myocardial infarction (Table 2).…”
Section: Resultsmentioning
confidence: 99%
“…To date, numerous publications have demonstrated a significant relationship between higher troponin values and worse prognosis in patients with acute myocardial infarction, heart failure or severe aortic valve disease [9][10][11][12][13]. It has also been described that TnT is a predictor of cardiac death in patients with CAD, atrial fibrillation or impaired left ventricular function [17][18][19][20][21]. However, Rahimi et al [22] did not show a significant correlation between postmortem TnT level and sudden death.…”
Section: Discussionmentioning
confidence: 99%